Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Rigontec GmbH
1616
Rigontec GmbH
Health Care
Medical
Therapeutics
Rigontec is the leader in RIG-I targeting RNA therapeutics developing novel immuno-oncology treatment options
Suggest edits
Founded
2014
Raised
$35.2M
Follow us
Companies in the same industry
Heartbeat Medical
PhiSkin
IRRAS
AAVLife
AZTherapies
Kesios Therapeutics
Nuritas
Hoth Therapeutics
Neuro Device Group
Evox Therapeutics Ltd
Alexa global traffic share
Overview
Funding
1
Add info
Latest funding
€15,000,000
Venture capital (Series A) - 2016
High-Tech Gruenderfonds
Sunstone Capital
MP Healthcare Venture Management
+3
Team Size
1–10
Employees
I work here
Location
Germany
Headquarters
Explore Germany
PE HUB
Merck to buy VC-backed Rigontec
Health
Funding
rigontec
Rigontec GmbH – A Dual Approach To Treat Cancer is a privately held biopharmaceutical company that develops RNA-based im...
Health
Science
Funding
€15,000,000
Venture capital (Series A)
FinSMEs
Rigontec Raises €15M in Third Closing of Series A Funding
Funding
Health
